Abstract:Toll-like Receptors (TLR) are major sensors of the innate immune system and are involved in the recognition of Pathogen Associated Molecular Patterns (PAMPs) and Damage Associated Molecular Patterns (DAMPs). When activated, TLR signaling pathways trigger an intracellular response that leads to the production of pro-inflammatory cytokines, chemotactic factors, antimicrobial peptides, and interferons. Overexpression of certain TLRs on neutrophils has been associated with increased mortality in patients with infection-induced shock, although the role of TLR4 overexpression is still debated. While TLRs play a role in recognizing in bacterial structures, they can also detect viral patterns, particularly TLR2, TLR3, and TLR7. The activation of the TLR signaling pathway is an early step recognizing viral genomic patterns of SARS-CoV-2 and its spike protein activates TLR4. In this prospective single-center observational cohort study, we conducted a comprehensive analysis of the protein expression of the ten known human TLR in white blood cells from patients with either bacterial and viral infections using flow cytometry, together with CD180, a 95-105 kDa TLR-like glycoprotein expressed on peripheral blood monocytes and B-lymphocytes. 73 patients were included, divided into 4 groups based on infection severity (sepsis, septic shock, moderate and severe COVID-19), along with 7 control subjects. Septic shock was assessed according to the third international consensus definition. COVID-19 patients with confirmed SARS-CoV-2 infection using reverse transcriptase-polymerase chain reaction (RT-PCR), admitted either to the emergency department (ED) or in the ICU were included. This study protocol was reviewed and approved by the local ethic committee, and written informed consent was obtained from participants of their relatives. For endosomal TLRs (TLR3, TLR7, TLR8, TLR9), plasma cell permeabilization was performed using the Perm2 Solution® (BD Biosciences, USA) prior to incubation of monoclonal antibodies staining. Cell surface expression was studied for the other TLRs. In neutrophils, antibody staining for TLR1-10 and CD180 revealed the expression of TLR4, with a large variation in positivity between groups, TLR8, TLR9 were also expressed, while TLR2, TLR3, and TLR7 were weakly expressed. In monocytes, only TLR2, TLR4, and CD180 were detected Notably, we observed a significant reduction in the expression of TLR4 and its co-receptor CD14 in neutrophils of patients with shock compared to controls (MFI=19 273 vs. 111 691, p<0.001 and MFI 2 028 vs. 3 025, p <0.02 respectively). Furthermore, severe COVID-19 patients exhibited a significant increase in TLR3 and TLR7 levels in neutrophils (p=0.003 and p=0.02 respectively) compared to the control group. Patients with shock also showed a similar increase in TLR7 expression in neutrophils, along with elevated intermediate monocytes compared to controls. TLR expression remained unchanged in lymphocytes. We also observed that CD16 expression in neutrophils was significantly lower in septic shock patients compared to healthy donors (p<0.0001), and to a lesser extent in sepsis patients (p<0.01), consistent with previous studies This study provided further insights into the mechanisms of TLR activation in various severe forms of infection. Additional analysis is required to assess their correlation with patient outcomes and evaluate the potential impact of TLR-related therapy on neutrophils activation.

Expression Levels of Cytokines and Chemokines Increase in Human Peripheral Blood Mononuclear Cells Stimulated by Activation of the Toll-like Receptor 5 Pathway.

Extensive Study of Cytokine, Chemokines Expression in Peripheral Blood Mononuclear Cells Upon CpG Stimulation

Heat Shock Up-Regulates Expression Of Toll-Like Receptor-2 And Toll-Like Receptor-4 In Human Monocytes Via P38 Kinase Signal Pathway

Activation of the TLR1/2 Pathway Induces the Shaping of the Immune Response Status of Peripheral Blood Leukocytes.

Stimulation of Toll-Like Receptors profoundly influences the titer of polyreactive antibodies in the circulation

Upregulation of Toll-like Receptor (TLR) expression and release of cytokines from mast cells by IL-12.

Gene Expression and Cytokine Secretion of Dendritic Cells Exposed to Different Toll-like Receptor Ligands

The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5

Inducible Microrna-223 Down-Regulation Promotes Tlr-Triggered Il-6 And Il-1 Beta Production In Macrophages By Targeting Stat3

Upregulation Of Toll-Like Receptor 2 Gene Expression In Macrophage Response To Peptidoglycan And High Concentration Of Lipopolysaccharide Is Involved In Nf-Kappa B Activation

Beyond Pattern Recognition: TLR2 Promotes Chemotaxis, Cell Adhesion, and Migration in THP-1 Cells

[Expression of TLR5 in different types of non-small cell lung cancer cell lines and its activation mechanism].

Secreted and intracellular cytokines are complementary measures for human monocytes treated with Toll-like receptor agonists

Researches on the Evolution,Function,and Related Diseases of TLR5

Cultured Human Melanocytes Express Functional Toll-like Receptors 2–4, 7 and 9

Interleukin‐21 Enhances Toll‐like Receptor 2/4‐mediated Cytokine Production Via Phosphorylation in the STAT3, Akt and P38 MAPK Signalling Pathways in Human Monocytic THP‐1 Cells

TLR5 Signaling Enhances the Proliferation of Human Allogeneic CD40-activated B Cell Induced CD4hiCD25+ Regulatory T Cells.

Expression of toll-like receptors in T lymphocytes stimulated with N-(3-oxododecanoyl)-L-homoserine lactone from Pseudomonas aeruginosa

TLR5 Signaling Stimulates the Innate Production of IL-17 and IL-22 by CD3(neg)CD127+ Immune Cells in Spleen and Mucosa.

TLR1-10 Protein Expression in Circulating Human White Blood Cells during Bacterial and COVID-19 Infections

Interplay of Chemokines Receptors, Toll-like Receptors, and Host Immunological Pathways